Hanbit Park
Overview
Explore the profile of Hanbit Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
317
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim Y, Yoon H, Suh J, Kang S, Lim Y, Jang D, et al.
JACC Cardiovasc Interv
. 2024 Nov;
18(2):187-197.
PMID: 39614852
Background: Recently developed artificial intelligence-based coronary angiography (AI-QCA, fully automated) provides real-time, objective, and reproducible quantitative analysis of coronary angiography without requiring additional time or labor. Objectives: This study aimed...
2.
Park H, Kang D, Ahn J, Yun S, Park K, Kang S, et al.
EuroIntervention
. 2024 Nov;
20(21):e1355-e1362.
PMID: 39492701
Despite the use of conventional dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), the risk of adverse events remains high among patients with increased thrombotic risk. Until recently, the...
3.
Kang D, Lee S, Lee S, Lee C, Kim C, Jang J, et al.
J Am Coll Cardiol
. 2024 Sep;
84(24):2380-2389.
PMID: 39217573
Background: Current guidelines recommend the perioperative continuation of aspirin in patients with coronary drug-eluting stents (DES) undergoing noncardiac surgery. However, supporting evidence is limited. Objectives: This study aimed to compare...
4.
Joh H, Kwon W, Shin D, Lee S, Hong Y, Hong D, et al.
JACC Asia
. 2024 Aug;
4(7):519-531.
PMID: 39101114
Background: There are limited clinical data on drug-coated balloon (DCB)-based percutaneous coronary intervention (PCI) compared with drug-eluting stent (DES)-only PCI in patients with complex coronary artery lesions. Objectives: The goal...
5.
Kim Y, Park H, Yoon H, Suh J, Kang S, Lim Y, et al.
Am Heart J
. 2024 May;
275:86-95.
PMID: 38723880
Background: Artificial intelligence-based quantitative coronary angiography (AI-QCA) has been developed to provide a more objective and reproducible data about the severity of coronary artery stenosis and the dimensions of the...
6.
Park H, Yang J, Ahn J, Kang D, Lee P, Kim T, et al.
Eur J Heart Fail
. 2023 Aug;
25(11):2037-2046.
PMID: 37642192
Aims: Few studies have reported data on the optimal timing of left ventricular (LV) unloading during venoarterial extracorporeal membrane oxygenation (VA-ECMO) for cardiac arrest or shock. This study evaluated the...
7.
Lee J, Ahn J, Kang D, Kim K, Koo H, Yang D, et al.
Am J Cardiol
. 2023 Jul;
203:352-361.
PMID: 37517131
It is unknown whether edoxaban versus dual antiplatelet therapy (DAPT) has differential treatment effects on leaflet thrombosis, cerebral thromboembolism, and neurologic or neurocognitive dysfunction according to clinical and anatomic factors...
8.
Park H, Kang D, Ahn J, Yang D, Koo H, Kang J, et al.
Am J Cardiol
. 2023 Feb;
192:212-220.
PMID: 36848690
Myocardial viability test to guide revascularization remains uncertain in patients with ischemic cardiomyopathy. We evaluated the different impacts of revascularization on cardiac mortality according to the extent of myocardial scar...
9.
Kim H, Kang D, Park H, Ahn J, Kim J, Kim S, et al.
JACC Asia
. 2022 Nov;
1(3):317-329.
PMID: 36341221
Background: Clinical advantages of sutureless rapid-deployment (RD) aortic valve replacement (AVR) for severe aortic valve stenosis (AS) have not been elucidated compared with surgical (SAVR) or transcatheter (TAVR) aortic valve...
10.
Jeong Y, Hyun J, Lee J, Kim J, Yang Y, Choe K, et al.
JACC Asia
. 2022 Nov;
2(2):182-193.
PMID: 36339122
Background: Limited data are available on the relative performances of diverse contemporary drug-eluting stents (DES) in patients undergoing complex high-risk indicated procedures (CHIP). Objectives: The purpose of this study was...